Literature DB >> 12039994

Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: simple and objective tools to define graft function.

Mahendra V Govani1, Osun Kwon, Thomas D Batiuk, Martin L Milgrom, Ronald S Filo.   

Abstract

To devise objective criteria for early diagnosis of delayed graft function (DGF), 59 adult living donor kidney transplants with immediate graft function (IGF) and 51 cadaveric kidney transplants were investigated for creatinine reduction ratio (CRR2) from posttransplant day 1 to day 2 and 24-h urine creatinine excretion (UC2) on day 2. The mean CRR2 in living donor transplants was 53% (SD +/- 11); the distribution of CRR2 was gaussian, and all of them had UC2 >1000 mg. Criteria for DGF were developed on the basis of living donor transplant: CRR2 < or =30% (2SD below 53%) +/- UC2 < or =1000 mg. Overall, 24 cadaver transplant recipients (47%) developed DGF (CRR2 < or =30%); 13 patients (25%) had mild DGF (UC2 >1000 mg), and the remaining 11 (22%) had severe DGF (UC2 < or =1000 mg). All the patients with severe DGF had a measured creatinine clearance <25 ml/min on day 7, and 8 of 11 were dialyzed within the first week of transplantation. Patients with IGF and mild DGF had a creatinine clearance of > or =25 ml/min on or before day 7, and none of them were dialyzed. Calcineurin inhibitors were avoided or delayed in five patients with mild DGF and all patients with severe DGF. In conclusion, diagnosing DGF within 48-h after transplantation is simple and may be valuable in the management of these patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039994     DOI: 10.1097/01.asn.0000014253.40506.f6

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  7 in total

Review 1.  Marked variation in the definition and diagnosis of delayed graft function: a systematic review.

Authors:  Sri G Yarlagadda; Steven G Coca; Amit X Garg; Mona Doshi; Emilio Poggio; Richard J Marcus; Chirag R Parikh
Journal:  Nephrol Dial Transplant       Date:  2008-04-11       Impact factor: 5.992

2.  Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes.

Authors:  Isaac E Hall; Peter P Reese; Mona D Doshi; Francis L Weng; Bernd Schröppel; William S Asch; Joseph Ficek; Heather Thiessen-Philbrook; Chirag R Parikh
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

3.  The predictive value of urinary kidney injury molecular-1 for long-term graft function in kidney transplant patients: a prospective study.

Authors:  Minyan Zhu; Zhejun Chen; Yuehan Wei; Yanhong Yuan; Liang Ying; Hang Zhou; Xiajing Che; Min Fang Zhang; Zhaohui Ni; Ming Zhang; Shan Mou
Journal:  Ann Transl Med       Date:  2021-02

4.  Association of pre-transplant statin use with delayed graft function in kidney transplant recipients.

Authors:  Janske Reiling; David W Johnson; Peter S Kruger; Peter Pillans; Daryl R Wall
Journal:  BMC Nephrol       Date:  2012-09-17       Impact factor: 2.388

5.  Study of The Effects of N-Acetylcysteine on Oxidative Stress Status of Patients on Maintenance-Hemodialysis Undergoing Cadaveric Kidney Transplantation.

Authors:  Atieh Modarresi; Shadi Ziaie; Jamshid Salamzadeh; Zahra Sahraei; Mohsen Nafar; Yunes Panahi; Mahmoud Parvin; Behzad Einollahi
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

6.  Association of Slow Graft Function with Long-Term Outcomes in Kidney Transplant Recipients.

Authors:  Connie J Wang; Ahmad Tuffaha; Milind A Phadnis; Jonathan D Mahnken; James B Wetmore
Journal:  Ann Transplant       Date:  2018-04-03       Impact factor: 1.530

7.  The use of thromboelastography to assess post-operative changes in coagulation and predict graft function in renal transplantation.

Authors:  Carson B Walker; Hunter B Moore; Trevor L Nydam; Alexander C Schulick; Hillary Yaffe; James J Pomposelli; Michael Wachs; Thomas Bak; Kendra Conzen; Megan Adams; Thomas Pshak; Rashikh Choudhury; Michael P Chapman; Elizabeth A Pomfret; Peter Kennealey
Journal:  Am J Surg       Date:  2020-08-27       Impact factor: 2.565

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.